AIMS: Glycosaminoglycan (GAG) layer replenishment is a cornerstone in the therapy of interstitial cystitis (IC). During the last years intravesical GAG layer replenishment has proven to be an effective treatment for overactive bladder (OAB), radiation cystitis, and recurrent urinary tract infections (UTIs). METHODS: Examination of different substances available for intravesical GAG replenishment and evaluation of the evidence for the treatment of the above-mentioned conditions. RESULTS: We searched the Medical Literature Analysis and Retrieval System Online (MEDLINE) database for studies on intravesical GAG replenishment. A total of 27 clinical studies remain relevant to this topic, many of them with mixed patient selection and suboptimal definition of symptom improvement/success. Two placebo controlled studies with hyaluronic acid failed to show superiority and have not been published. One active controlled randomized study has been published showing that chondroitin sulphate 0.2% has a clear benefit for OAB patients. Another study with chondroitin sulphate 2.0% failed to show statistically significant evidence, but was underpowered. CONCLUSIONS: A short number of randomized controlled studies confirm efficacy of intravesical GAG layer replenishment therapy. Concluded from the study background (which comprises also uncontrolled studies), so far chondroitin sulphate 0.2% is in favor for intravesical GAG layer replenishment therapy. In general, large-scale trials are urgently needed to underline the benefit of this type of therapy.
AIMS: Glycosaminoglycan (GAG) layer replenishment is a cornerstone in the therapy of interstitial cystitis (IC). During the last years intravesical GAG layer replenishment has proven to be an effective treatment for overactive bladder (OAB), radiation cystitis, and recurrent urinary tract infections (UTIs). METHODS: Examination of different substances available for intravesical GAG replenishment and evaluation of the evidence for the treatment of the above-mentioned conditions. RESULTS: We searched the Medical Literature Analysis and Retrieval System Online (MEDLINE) database for studies on intravesical GAG replenishment. A total of 27 clinical studies remain relevant to this topic, many of them with mixed patient selection and suboptimal definition of symptom improvement/success. Two placebo controlled studies with hyaluronic acid failed to show superiority and have not been published. One active controlled randomized study has been published showing that chondroitin sulphate 0.2% has a clear benefit for OABpatients. Another study with chondroitin sulphate 2.0% failed to show statistically significant evidence, but was underpowered. CONCLUSIONS: A short number of randomized controlled studies confirm efficacy of intravesical GAG layer replenishment therapy. Concluded from the study background (which comprises also uncontrolled studies), so far chondroitin sulphate 0.2% is in favor for intravesical GAG layer replenishment therapy. In general, large-scale trials are urgently needed to underline the benefit of this type of therapy.
Authors: Eileen M Geoghegan; Diana V Pastrana; Rachel M Schowalter; Upasana Ray; Wei Gao; Mitchell Ho; Gary T Pauly; Dina M Sigano; Campbell Kaynor; Ellen Cahir-McFarland; Benoit Combaluzier; Jan Grimm; Christopher B Buck Journal: Cell Rep Date: 2017-10-31 Impact factor: 9.423
Authors: Pierluigi Bonfili; Pietro Franzese; Francesco Marampon; Maria Emilia La Verghetta; Silvia Parente; Manuela Cerasani; Daniela Di Genova; Marta Mancini; Francesca Vittorini; Giovanni Luca Gravina; Valeria Ruggieri; Mario Di Staso; Vladimir M Popov; Vincenzo Tombolini; Ernesto Di Cesare Journal: Support Care Cancer Date: 2013-12-10 Impact factor: 3.603
Authors: Abigail Pulsipher; Xuan Qin; Andrew J Thomas; Glenn D Prestwich; Siam Oottamasathien; Jeremiah A Alt Journal: Int Forum Allergy Rhinol Date: 2016-11-11 Impact factor: 3.858
Authors: Thilo Schwalenberg; Frank Peter Berger; Lars Christian Horn; Phuc Ho Thi; Jens-Uwe Stolzenburg; Jochen Neuhaus Journal: Clin Drug Investig Date: 2015-08 Impact factor: 2.859
Authors: Heather Payne; Andrew Adamson; Amit Bahl; Jonathan Borwell; David Dodds; Catherine Heath; Robert Huddart; Rhona McMenemin; Prashant Patel; John L Peters; Andrew Thompson Journal: BJU Int Date: 2013-11 Impact factor: 5.588